Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare


Law firm for Life Sciences & Healthcare in Austria 

The legal issues in health care law—such as those arising from e-health solutions, personalised medicine or cost-cutting restructuring—are increasing in complexity and require the coordination of a variety of specialist areas. Our experts have diverse professional backgrounds and combine specialist know-how with many years of experience in the industry. For example, we assist hospitals, outpatient clinics and group practices to draft contracts for healthcare professionals, also  for operational management of hospitals ("kollegiale Führung"). In addition, we have gained in-depth knowledge about the applicable regulatory requirements from advising pharmaceutical, medical device and biotechnology companies, hospitals and pharmacies, as well as universities and interest groups

We are available to advise you on numerous issues, including:

•    Drafting strategic agreements,
•    Planning a corporate transaction,
•    Employment of healthcare professionals,
•    Implementing compliance requirements, and
•    Enforcement and defence of claims in court.

A strong international network in the Life Sciences & Healthcare field:

The CMS Life Sciences & Healthcare Sector Group consists of a team of over 300 lawyers, patent attorneys, scientists and academics from all over the world. Our clients include the 20 leading global pharmaceutical companies and the 10 leading global medical device companies. Many of our experts worked in the Life Sciences & Healthcare sector before joining CMS and have extensive knowledge of the industry.

Our legal advice in the healthcare sector

We advise our clients in the following specific areas:

•    Pharmaceutical law
•    Medical device law
•    Hospital and pharmacy law
•    Medical professional law
•    Preclinical and clinical studies

•    Reimbursement / market access
•    Licensing, research and development collaborations
•    Advertising and marketing
•    Antitrust and distribution law
•    Anti-corruption criminal law and compliance
•    Data protection
•    Patent, trademark, design and copyright law, protection certificates
•    Customs procedures, product piracy and parallel imports
•    Product liability law
•    Dispute resolution
•    Corporate law, M&A and financing
•    Tax law
•    Labour Law
•    Social security law
•    Contract partner law
•    Public procurement law
•    Plant protection
•    Narcotics law
•    Food Law

Stay up to date

Would you like to receive regular information from us? Sign up for our newsletter and receive useful information on events or other important legal developments by e-mail.

Get to know our lawyers for Life Sciences & Healthcare here.

Read more Read less

Choose area

    Medical Law

    Legal questions are becoming increasingly relevant in the medical field, driven in part by the intended austerity and restructuring mandates of recent years. How do health care institutions comply with the multitude of legal requirements and yet still remain commercially viable? This is just one of the many challenges that we can help you meet.

    Read more


    Show only
    New re­port­ing ob­lig­a­tion for sup­ply short­ages of pre­scrip­tion medi­cines
    Who is sub­ject to the re­port­ing ob­lig­a­tion? And what hap­pens if the ob­lig­a­tion to re­port short­ages of pre­scrip­tion medi­cines is not com­plied with?
    20 April 2020
    CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
    Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
    14 September 2020
    An EPO Case Law Round-Up: Ad­ded Mat­ter
    The EPO is well-known for its strict ap­proach to as­sess­ing amend­ments un­der the ad­ded mat­ter pro­vi­sion of Art­icle 123 of the European Pat­ent Con­ven­tion. This of­ten cre­ates com­plex leg­al scen­ari­os which...
    BREXIT: What do phar­ma­ceut­ic­al and med­ic­al device com­pan­ies need to do?
    CMS in­forms phar­ma­ceut­ic­al and med­ic­al device com­pan­ies, what they need to do fa­cing Brexit. Read more here ✓
    20 April 2020
    CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
    Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
    13 August 2020
    Sus­tain­able food pro­gress may close glob­al reg­u­lat­ory gap
    In­nov­a­tion in the sus­tain­able food sec­tor is for­ging ahead at a re­mark­able pace. Our cur­rent food sources ac­count for nearly one-third of glob­al GHG emis­sions while con­sumers are in­creas­ingly bet­ter edu­cated...
    Dis­tri­bu­tion and mar­ket­ing of drugs in Aus­tria: over­view
    A Q&A guide to dis­tri­bu­tion and mar­ket­ing of drugs law in Aus­tria
    22 July 2020
    Around 1600 view­ers re­gister for live video stream of com­puter soft­ware...
    The En­larged Board of the European Pat­ent Of­fice re­cently heard or­al ar­gu­ments con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion. This rare event was video streamed to over 1600 pat­ent stake­hold­ers....
    Lifes­ci­ences Ex­pert Gab­ri­ela Staber Ap­poin­ted Part­ner at CMS
    14 July 2020
    Santen ends Neur­im-style SPCs
    The word­ing of Art­icle 3(d) of the SPC Reg­u­la­tion re­quires that the SPC ap­plic­a­tion must rely on “the first au­thor­isa­tion to place the product on the mar­ket as a medi­cin­al product”. This sug­gests...
    For a healthy pro­spect
    Bro­chure Lifes­ci­ences
    08 July 2020
    “WIPO PROOF”: WIPO’s new on­line ser­vice which helps in­nov­at­ors and cre­at­ors...
    The World In­tel­lec­tu­al Prop­erty Or­gan­isa­tion (WIPO) re­cently launched its new on­line busi­ness ser­vice, “WIPO PROOF”. The plat­form aims to help in­nov­at­ors and cre­at­ors safe­guard their in­tel­lec­tu­al...